Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shirl Dipasquale"'
Autor:
Philip Sutera, MD, Matthew P. Deek, MD, Rebecca A. Deek, MS, Ozan Cem Guler, MD, Pervin Hurmuz, MD, Mehmet Reyhan, MD, Steven Rowe, MD, PhD, Noura Radwan, MD, Shirl Dipasquale, MSRN, William T. Hrinivich, PhD, Kathryn Lowe, MA, Lei Ren, PhD, Biren Saraiya, MD, Ronald Ennis, MD, Lara Hathout, MD, Tina Mayer, MD, Theodore L. Deweese, MD, Daniel Y. Song, MD, Ana Kiess, MD, Ezgi Oymak, MD, Kenneth Pienta, MD, Felix Feng, MD, Martin Pomper, MD, PhD, Gokhan Ozyigit, MD, Phuoc T. Tran, MD, PhD, Cem Onal, MD, Ryan M. Phillips, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 7, Pp 101507- (2024)
Purpose: Emerging data suggest that metastasis-directed therapy (MDT) improves outcomes in patients with oligometastatic castration-sensitive prostate cancer (omCSPC). Prostate-specific membrane antigen positron emission tomography (PSMA-PET) can det
Externí odkaz:
https://doaj.org/article/919f5deb98734f49825fc1c228a4a377
Autor:
Hamza Hasan, Matthew P. Deek, Ryan Phillips, Robert F. Hobbs, Reem Malek, Noura Radwan, Ana P. Kiess, Shirl Dipasquale, James Huang, Terry Caldwell, Jessica Leitzel, Danielle Wendler, Hao Wang, Elizabeth Thompson, Jonathan Powell, Sara Dudley, Curtiland Deville, Stephen C. Greco, Daniel Y. Song, Theodore L. DeWeese, Michael A. Gorin, Steven P. Rowe, Sam Denmeade, Mark Markowski, Emmanuel S. Antonarakis, Michael A. Carducci, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Channing J. Paller, Phuoc T. Tran
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Metastasis directed therapy (MDT) for patients with oligometastatic disease is associated with improvements in progression free survival (PFS) and overall survival (OS) compared to systemic therapy alone. Additionally, within a pr
Externí odkaz:
https://doaj.org/article/ce7f8bbe93b0463988e5fcc8db1a4287
Autor:
Phuoc T. Tran, Kathryn Lowe, Hua-Ling Tsai, Daniel Y. Song, Arthur Y. Hung, Jason W.D. Hearn, Steven Miller, James A. Proudfoot, Matthew P. Deek, Ryan Phillips, Tamara Lotan, Channing J. Paller, Catherine H. Marshall, Mark Markowski, Shirl Dipasquale, Samuel Denmeade, Michael Carducci, Mario Eisenberger, Theodore L. DeWeese, Matthew Orton, Curtiland Deville, Elai Davicioni, Stanley L. Liauw, Elisabeth I. Heath, Stephen Greco, Neil B. Desai, Daniel E. Spratt, Felix Feng, Hao Wang, Tomasz M. Beer, Emmanuel S. Antonarakis
Publikováno v:
Journal of Clinical Oncology. 41:1307-1317
PURPOSE We sought to investigate whether enzalutamide (ENZA), without concurrent androgen deprivation therapy, increases freedom from prostate-specific antigen (PSA) progression (FFPP) when combined with salvage radiation therapy (SRT) in men with re
Autor:
Sara A. Dudley, Jessica Leitzel, Martin G. Pomper, Reem Malek, Michael A. Gorin, Kenneth J. Pienta, Mark C. Markowski, Ryan Phillips, Danny Y. Song, Phuoc T. Tran, Matthew P. Deek, Ana P. Kiess, Mario A. Eisenberger, Elizabeth D. Thompson, Shirl Dipasquale, Jonathan D. Powell, Steven P. Rowe, Hao Wang, Emmanuel S. Antonarakis, Curtiland Deville, Stephen Greco, James Huang, Channing J. Paller, Robert F. Hobbs, Theodore L. DeWeese, Samuel R. Denmeade, Danielle Wendler, Hamza Hasan, Noura Radwan, Michael A. Carducci, Terry Caldwell
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Cancer
BMC Cancer
Background Metastasis directed therapy (MDT) for patients with oligometastatic disease is associated with improvements in progression free survival (PFS) and overall survival (OS) compared to systemic therapy alone. Additionally, within a prostate-ca
Autor:
Kenneth J. Pienta, Ash A. Alizadeh, Samuel R. Denmeade, Theodore L. DeWeese, Phuoc T. Tran, Steven P. Rowe, Mario A. Eisenberger, Ryan Phillips, Ashley E. Ross, Martin G. Pomper, Su Jin Lim, Adam P. Dicker, Shirl Dipasquale, Matthew P. Deek, Michael A. Carducci, William Shi, Danny Y. Song, Maximilian Diehn, Curtiland Deville, Emmanuel S. Antonarakis, Channing J. Paller, Michael A. Gorin, Hailun Wang, Hao Wang, Stephen Greco, Noura Radwan
Publikováno v:
JAMA Oncology. 6:650
Importance Complete metastatic ablation of oligometastatic prostate cancer may provide an alternative to early initiation of androgen deprivation therapy (ADT). Objective To determine if stereotactic ablative radiotherapy (SABR) improves oncologic ou
Autor:
Shirl Dipasquale, Matthew J. Weiss, Amanda L. Blackford, Ana De Jesus-Acosta, Daniel A. Laheru, Amy Hacker-Prietz, Siva P. Raman, Lauren M. Rosati, Joseph M. Herman, Shalini Moningi, Avani S. Dholakia, Dung T. Le, Christopher L. Wolfgang, John L. Cameron, Lei Zheng, Ryan Assadi, Timothy M. Pawlik
Publikováno v:
Annals of Surgical Oncology. 22:2352-2358
Stereotactic body radiation therapy (SBRT) is a promising option for patients with pancreatic cancer (PCA); however, limited data support its efficacy. This study reviews our institutional experience of SBRT in the treatment of locally advanced (LAPC